Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 66

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Blood-brain barrier leakage at baseline and cognitive decline in cerebral small vessel disease: a 2-year follow-up study

Kerkhofs, Danielle, Wong, Sau May, Zhang, Eleana, Uiterwijk, Renske, Hoff, Erik I., Jansen, Jacobus F. A., Staals, Julie, Backes, Walter H., van Oostenbrugge, Robert J.·2021·GeroScience

Abstract

Blood–brain barrier (BBB) dysfunction is one of the pathophysiological mechanisms in cerebral small vessel disease (SVD). Previously, it was shown that BBB leakage volume is larger in patients with SVD compared with controls. In this study, we investigated the link between BBB leakage and cognitive decline over 2 years in patients with cSVD. At baseline, 51 patients with clinically overt cSVD (lacunar stroke or mild vascular cognitive impairment) received a dynamic contrast-enhanced MRI scan to quantify BBB permeability in the normal-appearing white matter (NAWM), white matter hyperintensities (WMH), cortical grey matter (CGM), and deep grey matter (DGM). Cognitive function in the domain executive function, information processing speed, and memory was measured in all patients at baseline and after 2 years. The association between baseline BBB leakage and cognitive decline over 2 years was determined with multivariable linear regression analysis, corrected for age, sex, educational level, baseline WMH volume, and baseline brain volume. Regression analyses showed that higher baseline leakage volume and rate in the NAWM and CGM were significantly associated with increased overall cognitive decline. Furthermore, higher baseline leakage volume in the NAWM and CGM, and higher baseline leakage rate in the CGM were significantly associated with increased decline in executive function. This longitudinal study showed that higher BBB leakage at baseline is associated with stronger cognitive decline, specifically in executive function, over 2 years of follow-up in patients with cSVD. These results emphasize the key role of BBB disruption in the pathophysiology and clinical progression of cSVD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11357-021-00399-x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 33

  1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. · DOI · Paper page
  2. Wardlaw J, Sandercock P, Dennis M, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003;34(3):806–12. · DOI · Paper page
  3. Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron. 2017;96(1):17–42. · DOI · Paper page
  4. Stanimirovic DB, Friedman A. Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab. 2012;32(7):1207–21. · DOI · Paper page
  5. Zhang CE, Wong SM, van de Haar HJ, Staals J, Jansen JF, Jeukens CR, et al. Blood–brain barrier leakage is more widespread in patients with cerebral small vessel disease. Neurology. 2017;88(5):426–32. · DOI
  6. Li Y, Li M, Zhang X, Shi Q, Yang S, Fan H, et al. Higher blood–brain barrier permeability is associated with higher white matter hyperintensities burden. J Neurol. 2017;264(7):1474–81. · DOI
  7. Zhang CE, Wong SM, Uiterwijk R, Backes WH, Jansen JF, Jeukens CR, et al. Blood–brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging. Brain Imaging Behav. 2019;13(2):389–95. · DOI
  8. Wardlaw JM, Makin SJ, Hernández MCV, Armitage PA, Heye AK, Chappell FM, et al. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study. Alzheimers Dement. 2017;13(6):634–43. · DOI · Paper page
  9. Hainsworth AH, Minett T, Andoh J, Forster G, Bhide I, Barrick TR, et al. Neuropathology of white matter lesions, blood–brain barrier dysfunction, and dementia. Stroke. 2017;48(10):2799–804. · DOI
  10. Freeze WM, Jacobs HI, de Jong JJ, Verheggen IC, Gronenschild EH, Palm WM, et al. White matter hyperintensities mediate the association between blood-brain barrier leakage and information processing speed. Neurobiol Aging. 2020;85:113–22. · DOI
  11. Bamford J, Sandercock P, Jones L, Warlow C. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke. 1987;18(3):545–51. · DOI · Paper page
  12. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38. · DOI · Paper page
  13. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol. 1987;149(2):351–6. · DOI · Paper page
  14. Van De Haar HJ, Burgmans S, Jansen JF, Van Osch MJ, Van Buchem MA, Muller M, et al. Blood-brain barrier leakage in patients with early Alzheimer disease. Radiology. 2016;281(2):527–35. · DOI · Paper page
  15. Larsson HB, Courivaud F, Rostrup E, Hansen AE. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T1-weighted MRI at 3 tesla. Magn Reson Med. 2009;62(5):1270–81. · DOI
  16. De Boer R, Vrooman HA, Van Der Lijn F, Vernooij MW, Ikram MA, Van Der Lugt A, et al. White matter lesion extension to automatic brain tissue segmentation on MRI. Neuroimage. 2009;45(4):1151–61. · DOI · Paper page
  17. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825–41. · DOI · Paper page
  18. Lavini C, Verhoeff JJ. Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population. Magn Reson Imaging. 2010;28(10):1420–30. · DOI
  19. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985;5(4):584–90. · DOI · Paper page
  20. Wong SM, Jansen JF, Zhang CE, Hoff EI, Staals J, van Oostenbrugge RJ, et al. Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease. Neurology. 2019;92(15):e1669–77. · DOI
  21. Zhang CE, Wong SM, Uiterwijk R, Staals J, Backes WH, Hoff EI, et al. Intravoxel incoherent motion imaging in small vessel disease: microstructural integrity and microvascular perfusion related to cognition. Stroke. 2017;48(3):658–63. · DOI
  22. Brand N, Jolles J. Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol. 1985;112(2):201–10. · DOI · Paper page
  23. Wechsler D. WAIS-III Nederlandstalige bewerking. Technische handleiding. London: The Psychological Corporation; 2000.
  24. Reitan R. Trail Making Test: manual for administration, scoring and interpretation. Bloomington: Indiana University; 1956. p. 134.
  25. Luteyn F. Een nieuwe verkorte GIT. Dutch J Psychol. 1966;2:675–82.
  26. Lezak MD, Howieson DB, Loring DW, Fischer JS. Neuropsychological assessment. USA: Oxford University Press; 2004.
  27. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128(9):2034–41. · DOI · Paper page
  28. Hilal S, Sikking E, Shaik MA, Chan QL, Van Veluw SJ, Vrooman H, et al. Cortical cerebral microinfarcts on 3T MRI: a novel marker of cerebrovascular disease. Neurology. 2016;87(15):1583–90. · DOI
  29. Jouvent E, Mangin J-F, Duchesnay E, Porcher R, Düring M, Mewald Y et al. Longitudinal changes of cortical morphology in CADASIL. Neurobiology of aging. 2012;33(5):1002. e29-. e36. · DOI
  30. Lawrence AJ, Brookes RL, Zeestraten EA, Barrick TR, Morris RG, Markus HS. Pattern and rate of cognitive decline in cerebral small vessel disease: a prospective study. PloS one. 2015;10(8):e0135523. · DOI
  31. Uiterwijk R, van Oostenbrugge RJ, Huijts M, De Leeuw PW, Kroon AA, Staals J. Total cerebral small vessel disease MRI score is associated with cognitive decline in executive function in patients with hypertension. Front Aging Neurosci. 2016;8:301. · DOI
  32. O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2(2):89–98. · DOI · Paper page
  33. Verheggen IC, de Jong JJ, van Boxtel MP, Postma AA, Jansen JF, Verhey FR, et al. Imaging the role of blood–brain barrier disruption in normal cognitive ageing. GeroScience. 2020;42(6):1751–64. · DOI

Cited by

See all 66

Metadata

Authors
Kerkhofs, D., Wong, S. M., Zhang, E., Uiterwijk, R., Hoff, E. I., Jansen, J. F. A., Staals, J., Backes, W. H., & van Oostenbrugge, R. J.
Venue
GeroScience
Published
2021-06-23
Volume
43
Issue
4
Pages
1643-1652
ISSN
  • 2509-2715
  • 2509-2723
Cited by
66
References
9
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood-brain barrier leakage at baseline and cognitive decline in cerebral small vessel disease: a 2-year follow-up study. https://app.cochat.ai/papers/10.1007/s11357-021-00399-x
The paper
Kerkhofs, D., Wong, S. M., Zhang, E., Uiterwijk, R., Hoff, E. I., Jansen, J. F. A., Staals, J., Backes, W. H., & van Oostenbrugge, R. J. (2021). Blood-brain barrier leakage at baseline and cognitive decline in cerebral small vessel disease: a 2-year follow-up study. GeroScience. https://doi.org/10.1007/s11357-021-00399-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.